FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients Information about Express ...
Money Talks News on MSN
How a major FTC settlement could lower your out-of-pocket drug costs
A landmark deal aims to end the pricing games that grossly inflate what you pay at the pharmacy.
Cigna is following through on promises to more aggressively defend its pharmacy benefit manager. On Tuesday, the healthcare company’s PBM, Express Scripts, sued the Federal Trade Commission over the ...
Pharmacy benefit manager Express Scripts' lawsuit claiming the Federal Trade Commission defamed the company and industry as greedy in a scathing report will go nowhere as the government is generally ...
Cigna's Express Scripts Sues FTC Over Allegedly Defamatory Report "The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other ...
The FTC sued Cigna-owned Express Scripts, CVS-owned Caremark and UnitedHealth-owned Optum Rx in September, arguing that the drug middlemen prefer more expensive insulin products because they result in ...
Another major pharmacy benefit manager is adding Humira biosimilars to its formulary beginning next year. Express Scripts, which is part of Cigna's Evernorth subsidiary, said Monday that it will add ...
CVS Health's Caremark has become the second of the "Big Three" pharmacy benefit managers to reach a settlement with the Federal Trade Commission (FTC) in a lawsuit over insulin pricing. | CVS Health's ...
The Federal Trade Commission is starting an inquiry into the operations of pharmacy benefit managers who control access to prescription drugs for millions of Americans. The consumer protection agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results